Literature DB >> 27707980

Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: Systematic review with meta-analysis.

Akhilesh K Sista1, Larry E Miller2, Susan R Kahn3, Jeffrey A Kline4.   

Abstract

Long-term right ventricular (RV) function, functional capacity, exercise capacity, and quality of life following pulmonary embolism (PE), and the impact of thrombolysis, are unclear. A systematic review of studies that evaluated these outcomes with ⩾ 3-month mean follow-up after PE diagnosis was performed. For each outcome, random effects meta-analyses were performed. Twenty-six studies (3671 patients) with 18-month median follow-up were included. The pooled prevalence of RV dysfunction was 18.1%. Patients treated with thrombolysis had a lower, but not statistically significant, risk of RV dysfunction versus those treated with anticoagulation (odds ratio: 0.51, 95% CI: 0.24 to 1.13, p=0.10). Pooled prevalence of at least mild functional impairment (NYHA II-IV) was 33.2%, and at least moderate functional impairment (NYHA III-IV) was 11.3%. Patients treated with thrombolysis had a lower, but not statistically significant, risk of at least moderate functional impairment versus those treated with anticoagulation (odds ratio: 0.48, 95% CI: 0.15 to 1.49, p=0.20). Pooled 6-minute walk distance was 415 m (95% CI: 372 to 458 m), SF-36 Physical Component Score was 44.8 (95% CI: 43 to 46), and Pulmonary Embolism Quality of Life (QoL) Questionnaire total score was 9.1. Main limitations included heterogeneity among studies for many outcomes, variation in the completeness of data reported, and inclusion of data from non-randomized, non-controlled, and retrospective studies. Persistent RV dysfunction, impaired functional status, diminished exercise capacity, and reduced QoL are common in PE survivors. The effect of thrombolysis on RV function and functional status remains unclear.

Entities:  

Keywords:  functional capacity; meta-analysis; pulmonary embolism; quality of life; thrombolytic therapy

Mesh:

Substances:

Year:  2016        PMID: 27707980     DOI: 10.1177/1358863X16670250

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  19 in total

1.  The Post-Pulmonary Embolism Syndrome: Real or Ruse?

Authors:  Steven C Pugliese; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2019-07

Review 2.  How I use catheter-directed interventional therapy to treat patients with venous thromboembolism.

Authors:  Suresh Vedantham; Akhilesh K Sista
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

Review 3.  Short- and Long-term Mortality Risk After Acute Pulmonary Embolism.

Authors:  Rajesh Gupta; Dylan D Fortman; Daniel R Morgenstern; Christopher J Cooper
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

4.  Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: The iNOPE trial.

Authors:  Jeffrey A Kline; Cassandra L Hall; Alan E Jones; Michael A Puskarich; Ronald A Mastouri; Tim Lahm
Journal:  Am Heart J       Date:  2017-01-27       Impact factor: 4.749

5.  Cardiopulmonary Exercise Testing in Patients Following Massive and Submassive Pulmonary Embolism.

Authors:  Mazen S Albaghdadi; David M Dudzinski; Nicholas Giordano; Christopher Kabrhel; Brian Ghoshhajra; Michael R Jaff; Ido Weinberg; Aaron Baggish
Journal:  J Am Heart Assoc       Date:  2018-03-03       Impact factor: 5.501

6.  Long-Term Association of Venous Thromboembolism With Frailty, Physical Functioning, and Quality of Life: The Atherosclerosis Risk in Communities Study.

Authors:  Pamela L Lutsey; B Gwen Windham; Jeffrey R Misialek; Mary Cushman; Anna Kucharska-Newton; Saonli Basu; Aaron R Folsom
Journal:  J Am Heart Assoc       Date:  2020-06-01       Impact factor: 5.501

7.  Quality of life and functional limitations after pulmonary embolism and its prognostic relevance.

Authors:  Karsten Keller; Clara Tesche; Aslihan Gerhold-Ay; Stefan Nickels; Frederikus A Klok; Lisa Rappold; Gerd Hasenfuß; Claudia Dellas; Stavros V Konstantinides; Mareike Lankeit
Journal:  J Thromb Haemost       Date:  2019-08-13       Impact factor: 5.824

8.  Outpatient Pulmonary Rehabilitation in Patients with Persisting Symptoms after Pulmonary Embolism.

Authors:  Stephan Nopp; Frederikus A Klok; Florian Moik; Milos Petrovic; Irmgard Derka; Cihan Ay; Ralf Harun Zwick
Journal:  J Clin Med       Date:  2020-06-10       Impact factor: 4.241

9.  Long-term outcomes in patients with acute pulmonary embolism after in-hospital treatment: study protocol of the prospective Lungenembolie Augsburg Studie (LEA study).

Authors:  Christa Meisinger; Jakob Linseisen; Inge Kirchberger; Wolfgang von Scheidt; Thomas M Berghaus
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692

10.  One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism.

Authors:  Gregory Piazza; Keith M Sterling; Victor F Tapson; Kenneth Ouriel; Andrew S P Sharp; Ping-Yu Liu; Samuel Z Goldhaber
Journal:  Circ Cardiovasc Interv       Date:  2020-08-06       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.